Articles

Wall Street’s biggest bull reveals what investors got wrong this year — and what’s ahead for stocks and crypto

In a year defined by relentless volatility and uncertainty in financial markets, Tom Lee — Wall Street’s most vocal bull — remains unshakably optimistic and, to the frustration of bears, often correct.

Is the stock market open on Veterans Day? Will banks be closed?

The Nov. 11 holiday, which honors those who have served in the military, dates back to the end of World War I.

Nvidia’s stock has fallen due to AI bubble fears. Why analysts believe concerns are overblown.

Despite recent concerns about the AI trade, demand for Nvidia’s products remains as high as ever.

The steep price of housing is forcing Americans to delay marriage, kids and other milestones

More than half of aspiring homeowners in one recent survey believe that they will be 40 or older when they buy their first home.

Visa, Mastercard reach new settlement with merchants. Will it shake up credit-card rewards?

A proposed settlement in a long-running merchant lawsuit would give stores more freedom to block rewards cards, but it remains to be seen if they’d risk angering customers.

Here’s how high tariff rates would have to rise to bring manufacturing back to its glory days. Even Trump would be shocked.

Economists at UBS pointed to analysis done by the center-right American Enterprise Institute, which calculated that tariffs would have to be set at 42.5% to level out manufacturing imports and exports.

Who is reshaping the way we live, work, spend and invest? Meet the MarketWatch 25.

The leaders and thinkers whose ideas have impacted the way the government, companies and American society at large are grappling with technological change, higher prices and more.

Pfizer won its fight to buy an obesity-drug maker. It took an extra $1.7 billion and a phone call.

Pfizer is buying its way back into the obesity-drug game after fighting off a rival bid from Novo Nordisk to buy Metsera, with more money and help from the Trump administration.

Chanos declares victory in his bet vs. Strategy’s Saylor

Questions about Microstrategy’s business model, copycat products and a stalling in the bitcoin price might have contributed to the decline in MSTR’s mNAV.

How the math would work on a 50-year mortgage that Trump envisions

The key question, beyond the logistics of actually introducing such a product, is how much of a benefit in terms of affordability would it provide.

The lone bear on Meta’s stock foresaw its struggles — and sees more trouble ahead

BNP Paribas’s Stefan Slowinski warned about Meta’s unchecked AI spending. Now he thinks the stock’s recent selloff is just the beginning.

By one measure the bull market is 16 years old. Here’s why investors face a ‘challenging decade’ ahead.

Some of the long-term supportive tailwinds are shifting, according to MRB
1 142 143 144 145 146 2,561